NCT06283160View on ClinicalTrials.gov

METabolomic and Immune PROfiling in the Development of Pancreatic Fistulas After cepHalic duodEnopancreatectomy

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2026

Conditions
Pancreatic FistulaAcute PancreatitisPancreatoduodenectomy
Trial Locations (1)

25000

RECRUITING

University Hospital of Besançon, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER